EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer

Philip Mack, William S. Holland, Rebekah A. Burich, Randeep Sangha, Leslie J. Solis, Yueju Li, Laurel A Beckett, Primo N Lara, Angela M. Davies, David R Gandara

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences